Top

Reactions Weekly

Published in:

01-03-2023 | Fenofibrate | Case report

Fenofibrate/rituximab

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Smati S, et al. Remission d'une hypertriglyceridemie auto-immune severe apres traitement immunosuppresseur. Annales d'Endocrinologie 84: abstr. PB-374, No. 1, Feb 2023. Available from: URL: http://doi.org/10.1016/j.ando.2022.12.384 [French: summarised from a translation]

Title: Fenofibrate/rituximab
Lack of efficacy: case report
Publication date: 01-03-2023
Publisher: Springer International Publishing
Keywords: Fenofibrate
Azathioprine
Hashimoto Thyroiditis
Rituximab
Acute Pancreatitis
Rituximab
Azathioprine
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-36192-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Fenofibrate/rituximab

Lack of efficacy: case report

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Dapagliflozin

Bivalirudin/heparin

Antifungals

Amphotericin-b-liposomal/voriconazole

Dasatinib

Doxorubicin